Status:
COMPLETED
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
Lead Sponsor:
National Institute of Environmental Health Sciences (NIEHS)
Conditions:
Lupus
Eligibility:
All Genders
Brief Summary
This study is a continuing follow-up of patients with systemic lupus erythematosus (SLE) and control subjects enrolled in the Carolina Lupus Study and the University of North Carolina (UNC) Lupus Neph...
Detailed Description
Systemic lupus erythematosus (SLE) is a severe, chronic, disabling autoimmune disease that significantly affects health status and quality of life. Since the disease occurs most often in young to midd...
Eligibility Criteria
Inclusion
- ELIGIBILITY CRITERIA:
- Participants to be contacted for this follow-up study are enrolled as part of the Disease Progression and Activity in the Carolina Lupus Study (Protocol Number OH97-E-N002) and the UNC Nephritis Study (Lupus Nephritis: Role of Environmental and Occupational Exposures, Protocol Number 01-E-N154). There will be no new subject enrollment. Participants were initially recruited from collaborating hospitals and physicians in North and South Carolina. Recruitment ended in July, 1999.
- Lupus most often affects young women and this is shown by the makeup of study participants. The demographics of the study participants is described in Table 2. Most CLU participants were born in North or South Carolina. More than half of CLU patients are African Americans. There is no involvement of special classes of subjects.
Exclusion
Key Trial Info
Start Date :
December 16 2003
Trial Type :
OBSERVATIONAL
End Date :
October 26 2006
Estimated Enrollment :
716 Patients enrolled
Trial Details
Trial ID
NCT00339261
Start Date
December 16 2003
End Date
October 26 2006
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Environmental Health Sciences (NIEHS)
Bethesda, Maryland, United States, 20892